Free tools Windows power users keep installed

One-click scans. No signup required.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more

HIPAA does not classify a tool as compliant or noncompliant merely because it uses artificial intelligence. The legal analysis starts with three questions: Is your organization a HIPAA covered entity or business associate? Does the AI system create, receive, maintain, or transmit protected health information (PHI) for that organization? Is the communication marketing, and if so, does it require an individual authorization?

An AI chatbot in a provider’s patient portal that uses PHI for symptom assessment, medical reminders, or appointment scheduling is the kind of service HHS treats as a business-associate relationship. By contrast, software that never accesses PHI may not be a business associate on that basis alone. Marketing permission, vendor contracting, and security safeguards are separate decisions. State privacy laws and other federal requirements may also apply to the same campaign.

Start with the HIPAA roles, not the AI label

HIPAA’s Privacy, Security, and Breach Notification Rules apply to covered entities and business associates when they handle PHI in regulated workflows. Calling a product an AI platform, personalization engine, chatbot, analytics tool, or customer-data platform does not decide whether HIPAA applies.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

Which organizations are covered entities?

HHS defines covered entities to include health plans, healthcare clearinghouses, and healthcare providers that transmit health information electronically in connection with a covered transaction. Providing healthcare by itself is not the complete test; the provider’s role and electronic transactions matter.

Before a campaign or AI deployment, document the legal entity operating it, the entities sponsoring the communication, and whether each entity is acting as a covered entity, a business associate, or neither for the particular data flow. A corporate group can contain more than one role, so do not assume that a vendor, parent company, or marketing affiliate shares the same status as the provider.

When can an AI supplier be a business associate?

A business associate performs certain functions or services for a covered entity involving PHI. HHS says a vendor that merely supplies software without access to PHI is not a business associate on that basis alone. A vendor that needs access to PHI to provide its service may be one.

HHS uses a third-party AI chatbot in a provider’s patient portal as an example. If the chatbot handles a patient’s symptoms, reminders, or appointment information for the provider, the service relationship and access to PHI need to be evaluated as a business-associate arrangement. The same product could have a different analysis in a configuration that receives no PHI.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

What if the organization is neither?

If an organization is not a covered entity or business associate, HIPAA may not govern its activity under that rule. That is not a general permission to collect health information. State consumer-privacy laws, breach-notification laws, communications rules, contractual duties, and other federal requirements can still apply. Obtain jurisdiction-specific advice before treating a non-HIPAA conclusion as a green light.

Map every AI data flow before activating personalization

The practical question is what information leaves your environment, who can access it, and why. Create a written data-flow map for the exact campaign and configuration rather than relying on a vendor’s product category or a checkbox labeled “HIPAA-ready.”

  1. List inputs. Record prompts, uploaded files, form fields, appointment details, account identifiers, URLs, device identifiers, free-text messages, and any data copied from a patient record or customer relationship system.
  2. List processing locations and recipients. Identify the AI service, hosting environment, analytics providers, logging systems, support personnel, and subprocessors that can receive or view the information.
  3. List outputs and secondary uses. Capture generated text, audience segments, scores, recommendations, moderation records, debugging data, and reports. An output or log that contains information about an individual may require the same care as the input.
  4. Document retention and deletion. Record how long prompts, outputs, logs, backups, and support tickets remain available, and which party controls deletion.
  5. Mark access paths. Note whether access is authenticated, role-based, human-reviewed, available through an API, or exposed to a model-training or quality-improvement process.
  6. Classify the information in context. Removing a name after a vendor has already received a patient-related record does not automatically cure the disclosure. Determine whether the information is PHI at the time it is collected or disclosed and whether the recipient’s role changes the analysis.
Data-flow checkpoint Questions to answer Why it matters
Prompt or upload What exact fields and free text can a marketer or patient submit? Unexpected health details can enter an otherwise ordinary workflow.
Model processing Can the provider, vendor, subprocessor, or support team access the content? Access can establish a service relationship involving PHI.
Output and logs Are responses, transcripts, identifiers, or error logs retained? Secondary copies can create additional PHI-handling locations.
Audience activation Does a segment, score, or event go to an advertising or messaging recipient? The disclosure’s purpose and recipient determine whether marketing authorization is needed.
Deletion and controls Who can delete data, and what safeguards restrict access? Contractual and security obligations must match the real workflow.

Apply the HIPAA marketing rule to the actual communication

HHS generally requires an individual’s authorization for uses or disclosures of PHI for marketing, subject to limited exceptions. HHS describes marketing as a communication about a product or service that encourages the recipient to purchase or use it.

Third-party product promotion

If PHI is disclosed so another entity can market its own product or service, HHS says authorization is required. A patient list cannot be sold or disclosed for a third party’s independent marketing without the required authorization. The fact that an AI system selected the audience, wrote the copy, or delivered the message does not change the purpose of the disclosure.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

Communications that may fall outside marketing

Some communications are not marketing under HHS’s description. These include communications about the covered entity’s own health-related product or service and certain general health-promotion communications. Being outside the marketing definition does not remove other Privacy Rule duties, so classify the communication rather than assuming an exception.

Communication pattern Initial classification question Practical action
Provider promotes its own health-related service Is the provider communicating about its own product or service? Check whether the communication fits HHS’s non-marketing category, then review all other Privacy Rule requirements.
General health promotion Is the message general education or health promotion rather than encouragement to buy a product? Analyze the purpose, sponsor, audience, and PHI used; do not rely on the label “wellness.”
Another company’s product Is PHI being disclosed so another entity can market independently? Obtain the individual authorization required for that disclosure before activation.
AI-personalized message Did the model use PHI to choose, tailor, or deliver the communication? Evaluate the underlying use and disclosure; automation does not create a marketing exception.

Keep a record of the sponsor, purpose, data used, recipient, channel, and exception relied on. Those facts are more useful than a generic claim that a campaign is “engagement” or “education.”

Use the vendor and BAA decision path

A business associate agreement (BAA) addresses a vendor relationship and required safeguards. It is not a substitute for a patient’s marketing authorization.

  1. Identify the organization’s role. Confirm whether the organization is a covered entity, business associate, or neither for this workflow. For providers, examine whether electronic health-information transactions place the entity within the covered-entity definition.
  2. Trace the data. Record prompts, uploads, outputs, logs, analytics, retention, subprocessors, and every way the vendor can access PHI. Do not assume that de-identification after receipt eliminates the original disclosure.
  3. Decide whether the vendor is a business associate. A software supplier with no PHI access is not a business associate merely because it sells software. A service that needs PHI access to perform work for the covered entity may be one; the patient-portal AI chatbot is HHS’s illustrative case.
  4. Sign a written BAA before the PHI workflow. HHS says the agreement must establish permitted and required uses and disclosures, safeguards, and other required terms. Make sure the contract reflects actual retention, support access, subprocessors, incident handling, and deletion practices.
  5. Review marketing permission separately. A BAA does not authorize a use or disclosure that would violate the Privacy Rule if the covered entity performed it. If the campaign requires an individual authorization, obtain and manage that authorization independently of the vendor contract.

Review pixels, cookies, SDKs, and other tracking technologies

HHS’s Office for Civil Rights states: “The HIPAA Rules apply when the information that regulated entities collect through tracking technologies or disclose to tracking technology vendors includes protected health information (PHI).” The statement appears in OCR’s guidance on online tracking technologies used by HIPAA covered entities and business associates.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

The guidance discusses pixels, cookies, session-replay scripts, fingerprinting, and mobile identifiers. A cookie banner or general privacy notice does not by itself create HIPAA permission or a valid authorization for a PHI disclosure. The question is what information the regulated entity collects or sends, in what context, and to whom.

Understand the June 20, 2024 court development

On June 20, 2024, the U.S. District Court for the Northern District of Texas vacated the tracking guidance insofar as it treated a connection between an IP address and a visit to certain unauthenticated condition- or provider-related pages as sufficient by itself to trigger HIPAA. HHS says it is evaluating next steps.

This is a scoped vacatur, not a blanket ruling that tracking tools are outside HIPAA. Because the online guidance and its legal status can change, check the current HHS page and obtain legal review for a particular data flow.

Tracking review checklist

  • Inventory every tag, pixel, SDK, session-replay script, analytics call, and fingerprinting mechanism.
  • Capture the exact URLs, form values, account events, appointment events, device identifiers, and user inputs that leave the site or app.
  • Assess whether each field becomes PHI in context, including the relationship between the identifier, the page or event, and the individual.
  • Identify every recipient and determine whether it is a business associate, another service provider, or an independent marketer.
  • Confirm the required permission, authorization, BAA, and safeguards before sending the event.
  • Minimize fields, disable unnecessary sharing, restrict access, and document the approved configuration.

Give higher scrutiny to sensitive channels

Authenticated portals, registration and login flows, appointment scheduling, and mobile apps that handle patient information deserve especially careful review. These channels can combine account identifiers, appointment events, messages, and user-entered health details even when a marketer did not intend to collect clinical information.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

Public pages also require contextual analysis. A page’s public availability does not automatically resolve whether a tracking event, URL, search term, or identifier is PHI. Conversely, the 2024 court order narrowed one specific proposition about unauthenticated condition- or provider-related pages; it did not decide every tracking scenario.

Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Support on Ko-Fi

Common failure modes and how to correct them

“The tool is advertised as HIPAA compliant, so we can use it.”

Why it fails: Product language does not determine your role, the data disclosed, or the vendor’s access. Correction: map the actual configuration, recipients, retention, and safeguards, then decide whether a BAA and authorization are required.

“We signed a BAA, so marketing is allowed.”

Why it fails: A BAA governs the business-associate relationship; it does not supply an individual authorization for a marketing use or third-party disclosure. Correction: run the marketing analysis separately and retain evidence of the authorization or applicable exception.

“The cookie banner covers our pixels.”

Why it fails: Notice or consent language alone is not a HIPAA permission or valid authorization. Correction: identify the PHI, recipient, purpose, and legal permission for each event before deployment.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

“We remove names after the AI vendor receives the file.”

Why it fails: Later removal does not automatically erase the original disclosure or change the vendor’s access during processing. Correction: assess the information and recipient at collection and transmission time, and minimize it before disclosure.

“All health content is marketing” or “none of it is.”

Why it fails: HHS distinguishes certain communications about a covered entity’s own services and some general health promotion from marketing, while third-party promotion can require authorization. Correction: document the sponsor, purpose, audience, data, recipient, and exception for each communication.

A practical approval sequence for healthcare marketing teams

  1. Write the campaign objective in plain language and name the sponsoring entity.
  2. Classify the organization’s HIPAA role for the exact workflow.
  3. Draw the data flow from collection through AI processing, logging, analytics, delivery, and deletion.
  4. Mark every PHI field, identifier, event, prompt, output, and recipient.
  5. Classify the communication under the marketing rule, including any own-service or general-health-promotion exception.
  6. Complete the vendor analysis and execute a BAA before PHI access when required.
  7. Obtain individual authorization when the use or disclosure requires it; do not treat the BAA or cookie notice as a replacement.
  8. Review tracking technology separately, with special attention to authenticated areas, registration, appointments, and mobile apps.
  9. Minimize data and access, record retention and deletion settings, and obtain legal approval for unresolved facts.
  10. Recheck the current HHS tracking guidance and applicable state requirements when the campaign, vendor, or legal landscape changes.

Bottom line

Healthcare marketers should treat AI as a data-flow and role question, not as a special HIPAA category. Determine whether the organization is covered, whether the system handles PHI on its behalf, whether the communication is marketing, and which permissions and contracts apply. A BAA can establish safeguards for a business associate, but it cannot replace marketing authorization. Tracking pixels and analytics require the same contextual review when they collect or disclose PHI, and the 2024 court order changed only a defined part of OCR’s unauthenticated-page analysis.

Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.